The challenge of imaging-guided therapeutic management

Bove AA, Santamore WP, Homko C, Kashem A, Cross R, McConnell TR, et al. Treatment of patients with intermediate cardiovascular risk: are clinical measures enough? J Nucl Cardiol 2011. doi:10.1007/s12350-011-9415-7.

Califf, 1996, 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management, J Am Coll Cardiol, 27, 1007, 10.1016/0735-1097(96)87733-3

Greenland, 2010, 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 56, e50, 10.1016/j.jacc.2010.09.001

Ridker, 2008, Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein, N Engl J Med, 359, 2195, 10.1056/NEJMoa0807646

Oudkerk, 2008, Coronary artery calcium screening: Current status and recommendations from the European Society of Cardiac Radiology and North American Society for Cardiovascular Imaging, Int J Cardiovasc Imaging, 24, 645, 10.1007/s10554-008-9319-z

Arad, 2005, Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial, J Am Coll Cardiol, 46, 166, 10.1016/j.jacc.2005.02.089

Taylor, 2008, Community-based provision of statin and aspirin after the detection of coronary artery calcium within a community-based screening cohort, J Am Coll Cardiol, 51, 1337, 10.1016/j.jacc.2007.11.069

Rozanski, 2011, Impact of coronary artery calcium scanning on coronary risk factors and downstream testing the EISNER (early identification of subclinical atherosclerosis by noninvasive imaging research) prospective randomized trial, J Am Coll Cardiol, 57, 1622, 10.1016/j.jacc.2011.01.019